The total return over the past 12 months is +35.12% vs. +19.98% for the S&P 500. So far it's up +17.45% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +32.31% | (2.69%) | +1.47% | +12.61% | +13.35% | +8.68% |
| Total Return CAGR | +35.12% | (1.08%) | +2.95% | +14.18% | +15.07% | +9.95% |
| Revenue CAGR | +6.27% | +6.67% | +9.25% | +9.41% | +8.49% | +7.14% |
| Net Income CAGR | (7.41%) | (7.69%) | +3.24% | +7.91% | +3.61% | +2.95% |
| EPS CAGR | (4.50%) | (0.39%) | +6.67% | +9.97% | +8.28% | +9.59% |
| Free Cash Flow CAGR | +17.84% | (15.89%) | (19.97%) | +9.24% | +5.21% | +2.63% |
| Operating Cash Flow CAGR | +15.65% | (14.22%) | +1.73% | +8.64% | +5.44% | +3.31% |
| Dividends CAGR | +4.91% | +10.13% | +12.48% | +10.59% | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Elevance Health Inc. (ELV)
| Year | Start price | End price | ELV Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $350.55 | $407.50 | +17.45% | +13.55% | +3.90% |
| 2025 | $368.90 | $350.55 | (3.12%) | +17.72% | (20.84%) |
| 2024 | $471.56 | $368.90 | (20.71%) | +24.89% | (45.60%) |
| 2023 | $512.97 | $471.56 | (6.90%) | +26.19% | (33.09%) |
| 2022 | $463.54 | $512.97 | +11.82% | (18.17%) | +29.99% |
| 2021 | $321.09 | $463.54 | +46.13% | +28.74% | +17.39% |
| 2020 | $302.03 | $321.09 | +7.73% | +18.37% | (10.64%) |
| 2019 | $262.63 | $302.03 | +16.33% | +31.22% | (14.89%) |
| 2018 | $225.01 | $262.63 | +18.11% | (4.56%) | +22.67% |
| 2017 | $143.77 | $225.01 | +58.73% | +21.70% | +37.03% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
